Eric Thomas Schmidt - Net Worth and Insider Trading

Eric Thomas Schmidt Net Worth

The estimated net worth of Eric Thomas Schmidt is at least $4 Million dollars as of 2024-04-24. Eric Thomas Schmidt is the CFO of Allogene Therapeutics Inc and owns about 1,253,141 shares of Allogene Therapeutics Inc (ALLO) stock worth over $4 Million. Details can be seen in Eric Thomas Schmidt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Thomas Schmidt has not made any transactions after 2022-03-15 and currently still holds the listed stock(s).

Transaction Summary of Eric Thomas Schmidt

To

Eric Thomas Schmidt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Thomas Schmidt owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , Revolution Medicines Inc (RVMD) , and Relmada Therapeutics Inc (RLMD) .

Click here to see the complete history of Eric Thomas Schmidt’s form 4 insider trades.

Insider Ownership Summary of Eric Thomas Schmidt

Ticker Comapny Transaction Date Type of Owner
ALLO Allogene Therapeutics Inc 2022-03-15 Chief Financial Officer
RVMD Revolution Medicines Inc 2020-06-17 director
RLMD Relmada Therapeutics Inc 2019-12-19 director

Eric Thomas Schmidt Latest Holdings Summary

Eric Thomas Schmidt currently owns a total of 1 stock. Eric Thomas Schmidt owns 1,253,141 shares of Allogene Therapeutics Inc (ALLO) as of March 15, 2022, with a value of $4 Million.

Latest Holdings of Eric Thomas Schmidt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALLO Allogene Therapeutics Inc 2022-03-15 1,253,141 3.06 3,834,611

Holding Weightings of Eric Thomas Schmidt


Eric Thomas Schmidt Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Thomas Schmidt has made a total of 7 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 11,469 shares on March 15, 2022, which brought Eric Thomas Schmidt around $87,509.

Insider Trading History of Eric Thomas Schmidt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Thomas Schmidt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric Thomas Schmidt Ownership Network

Ownership Network List of Eric Thomas Schmidt

No Data

Ownership Network Relation of Eric Thomas Schmidt


Eric Thomas Schmidt Owned Company Details

What does Allogene Therapeutics Inc do?

Who are the key executives at Allogene Therapeutics Inc?

Eric Thomas Schmidt is the Chief Financial Officer of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include CHIEF FINANCIAL OFFICER Geoffrey M. Parker , GENERAL COUNSEL Earl Martin Douglas , and SVP & Finance Yinlin Jack Chen .

Allogene Therapeutics Inc (ALLO) Insider Trades Summary

Over the past 18 months, Eric Thomas Schmidt made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 11,602 shares made by Veer Bhavnagri , a net sale of 18,640 shares made by Deborah M. Messemer , and a net sale of 10,000 shares made by Stephen Mayo .

In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 190 shares, with a net purchase of 190 shares. During the past 18 months, 40,242 shares of Allogene Therapeutics Inc (ALLO) were sold and 190 shares were bought by its insiders, resulting in a net sale of 40,052 shares.

Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allogene Therapeutics Inc Insider Transactions

No Available Data

Eric Thomas Schmidt Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Thomas Schmidt. You might contact Eric Thomas Schmidt via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.

Discussions on Eric Thomas Schmidt

No discussions yet.